Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Aydin Kavara"'
Autor:
Adam Hejmowski, Michelle Olson, Anne MacIntyre, Amanda Rose, Kurt Boenning, Julio Huato, Mark Schofield, Aydin Kavara, Nick Marchand, Mike Collins
Publikováno v:
Cell and Gene Therapy Insights. 7:1563-1579
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e468571b7bd4ff9fe4f037ed4d79f4d
https://doi.org/10.18609/cgti.2021.211
https://doi.org/10.18609/cgti.2021.211
Understanding scalability of mustang® Q Devices in lentiviral vector purification using DOE approach
Autor:
Ana Moreira, Adam Hejmowski, Kurt Boenning, manuel carrondo, Julio Huato, Aydin Kavara, Todd Sanderson, Mark Schofield, Rene Gantier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c5a70ab9eef724df305d67da77ce50
https://doi.org/10.1021/scimeetings.0c07221
https://doi.org/10.1021/scimeetings.0c07221
Autor:
John P. Amara, David M. Bohonak, Benjamin Cacace, Mike Collins, Brandon Coyle, Paul W. Genest, Mirna González-González, Elizabeth M. Goodrich, Elina Gousseinov, Akshat Gupta, Sophia Hober, Sara Kanje, Aydin Kavara, Kelley Kearns, John F. Kelly, Warren Kett, Karol Lacki, Yifeng Li, Allan Matte, Karla Mayolo-Deloisa, Anup Mohanty, Johan Nilvebrant, Emily Peterson, Marco Rito-Palomares, Anna C. Robotham, Thomas Scanlon, Julia Scheffel, Mark Schofield, Peter (Keqiang) Shen, David Sokolowski, Ying Wang, Weichang Zhou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1694da13bee88b696de9bdc1e5133d40
https://doi.org/10.1016/b978-0-08-103019-6.01002-x
https://doi.org/10.1016/b978-0-08-103019-6.01002-x
The biopharmaceutical industry is maturing, which is leading to increased competition and regulatory expectations. We discuss these pressures on the biopharmaceutical industry and the drive to reduce cost and improve quality and flexibility. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45f77b05e753027a494361aaedf9133f
https://doi.org/10.1016/b978-0-08-103019-6.00004-7
https://doi.org/10.1016/b978-0-08-103019-6.00004-7
Publikováno v:
Biotechnology Journal. 17:2100219
A challenge in the production of recombinant Adeno-Associated Virus (AAV) for gene therapies is the presence of capsids that lack the required gene of interest. The impact of these empty vectors in therapies is not fully understood, however the abili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::833f1017ce065a0951602c62f71fe865
https://doi.org/10.1002/biot.202100219
https://doi.org/10.1002/biot.202100219